'Why we do What we do in Cardiology'

CHF: Major News and Trial Updates in CHF in 2023

Listen Later

A quick rundown of the key developments:

Trials:

  • STEP-HFpEF
  • CASTLE-HTx
  • HEART FID
  • DAPA-MI

    • Policy and Guidelines:

    • ESC cardiomyopathy guidelines
    • Inflation Reduction Act
    • FDA approvals: dapagliflozin and sotagliflozin

      • Other Highlights:

      • The world's second-living patient with end-stage heart failure received a genetically modified pig heart transplant but sadly died after 6 weeks due to transplant rejection.
      • The ARIES-HCM3 trial
      • The PUSH AHF trial
      • The QUEST trial from China
      • Declining interest in advanced heart failure and transplant cardiology fellowships



        • ...more
        View all episodesView all episodes
        Download on the App Store
        'Why we do What we do in Cardiology'By Bishnu Subedi

        More shows like 'Why we do What we do in Cardiology'

        View all
        This Week in Cardiology by Medscape

        This Week in Cardiology

        906 Listeners

        Core IM | Internal Medicine Podcast by Core IM Team

        Core IM | Internal Medicine Podcast

        1,150 Listeners